About
Hyunkoo Kang is a Research Fellow in the Department of Neurosurgery at Yale School of Medicine. Their research focuses on understanding the molecular mechanisms underlying cancer radioresistance and metabolic reprogramming in glioblastoma. Key areas include investigating how mitochondrial lipid metabolism, glycolytic flux, and autophagy pathways contribute to tumor survival under radiation stress. Kang's work integrates biochemical, molecular, and pharmacological approaches to identify novel therapeutic targets for overcoming treatment resistance. They have contributed to studies on DGKB, CLIP3, and NRBF2 proteins, as well as exosomal signaling in cancer progression.
Recent investigations explore the Warburg effect's role in radioresistance and the development of biosensors for endocrine-disrupting chemicals. Their findings have been published in high-impact journals, emphasizing translational applications in oncology and radiation biology.
